 | • レポートコード：QYR2104Z3284 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、虚血再灌流障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フェーズ1、フェーズ2、前臨床）、用途別市場規模（心臓傷害、腎臓傷害、腸傷害、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・虚血再灌流障害の市場動向 ・企業の競争状況、市場シェア ・虚血再灌流障害の種類別市場規模（フェーズ1、フェーズ2、前臨床） ・虚血再灌流障害の用途別市場規模（心臓傷害、腎臓傷害、腸傷害、その他） ・虚血再灌流障害の北米市場規模2016-2027（アメリカ、カナダ） ・虚血再灌流障害のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・虚血再灌流障害のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・虚血再灌流障害の中南米市場規模2016-2027（メキシコ、ブラジル） ・虚血再灌流障害の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Angion Biomedica、Catalyst Biosciences、Ischemix Inc、Opsona Therapeutics、Pharming、TheraSource、Bolder Biotechnology、Corline Biomedical、Mifcortx、Balmes Transplantation、NovelMed Therapeutics、Hope Pharmaceuticals、Omeros Corp、Prothix、SBI Pharmaceuticals） ・結論 |
Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.
Ischemic reperfusion injury is the tissue damage that happens when blood supply returns to the tissue after a period of lack of oxygen. The absence of oxygen and nutrients creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative. Symptoms include headache, bradycardia, seizures and hypertension. Risk factors include hypertension, hyperlipidemia, diabetes, insulin resistance, heart failure, altered coronary circulation, and aging.
Market Analysis and Insights: Global Ischemia Reperfusion Injury Market
The global Ischemia Reperfusion Injury market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ischemia Reperfusion Injury market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ischemia Reperfusion Injury market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ischemia Reperfusion Injury market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ischemia Reperfusion Injury market.
Global Ischemia Reperfusion Injury Scope and Market Size
Ischemia Reperfusion Injury market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ischemia Reperfusion Injury market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Phase 1
Phase 2
Preclinical
Segment by Application
Heart Injury
Kidney Injury
Intestine Injury
Other Injury
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Opsona Therapeutics
Pharming
Hope Pharmaceuticals
Omeros Corp
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ischemia Reperfusion Injury Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Phase 1
1.2.3 Phase 2
1.2.4 Preclinical
1.3 Market by Application
1.3.1 Global Ischemia Reperfusion Injury Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Heart Injury
1.3.3 Kidney Injury
1.3.4 Intestine Injury
1.3.5 Other Injury
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ischemia Reperfusion Injury Market Perspective (2016-2027)
2.2 Ischemia Reperfusion Injury Growth Trends by Regions
2.2.1 Ischemia Reperfusion Injury Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ischemia Reperfusion Injury Historic Market Share by Regions (2016-2021)
2.2.3 Ischemia Reperfusion Injury Forecasted Market Size by Regions (2022-2027)
2.3 Ischemia Reperfusion Injury Industry Dynamic
2.3.1 Ischemia Reperfusion Injury Market Trends
2.3.2 Ischemia Reperfusion Injury Market Drivers
2.3.3 Ischemia Reperfusion Injury Market Challenges
2.3.4 Ischemia Reperfusion Injury Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ischemia Reperfusion Injury Players by Revenue
3.1.1 Global Top Ischemia Reperfusion Injury Players by Revenue (2016-2021)
3.1.2 Global Ischemia Reperfusion Injury Revenue Market Share by Players (2016-2021)
3.2 Global Ischemia Reperfusion Injury Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ischemia Reperfusion Injury Revenue
3.4 Global Ischemia Reperfusion Injury Market Concentration Ratio
3.4.1 Global Ischemia Reperfusion Injury Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ischemia Reperfusion Injury Revenue in 2020
3.5 Ischemia Reperfusion Injury Key Players Head office and Area Served
3.6 Key Players Ischemia Reperfusion Injury Product Solution and Service
3.7 Date of Enter into Ischemia Reperfusion Injury Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ischemia Reperfusion Injury Breakdown Data by Type
4.1 Global Ischemia Reperfusion Injury Historic Market Size by Type (2016-2021)
4.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2022-2027)
5 Ischemia Reperfusion Injury Breakdown Data by Application
5.1 Global Ischemia Reperfusion Injury Historic Market Size by Application (2016-2021)
5.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ischemia Reperfusion Injury Market Size (2016-2027)
6.2 North America Ischemia Reperfusion Injury Market Size by Type
6.2.1 North America Ischemia Reperfusion Injury Market Size by Type (2016-2021)
6.2.2 North America Ischemia Reperfusion Injury Market Size by Type (2022-2027)
6.2.3 North America Ischemia Reperfusion Injury Market Size by Type (2016-2027)
6.3 North America Ischemia Reperfusion Injury Market Size by Application
6.3.1 North America Ischemia Reperfusion Injury Market Size by Application (2016-2021)
6.3.2 North America Ischemia Reperfusion Injury Market Size by Application (2022-2027)
6.3.3 North America Ischemia Reperfusion Injury Market Size by Application (2016-2027)
6.4 North America Ischemia Reperfusion Injury Market Size by Country
6.4.1 North America Ischemia Reperfusion Injury Market Size by Country (2016-2021)
6.4.2 North America Ischemia Reperfusion Injury Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Ischemia Reperfusion Injury Market Size (2016-2027)
7.2 Europe Ischemia Reperfusion Injury Market Size by Type
7.2.1 Europe Ischemia Reperfusion Injury Market Size by Type (2016-2021)
7.2.2 Europe Ischemia Reperfusion Injury Market Size by Type (2022-2027)
7.2.3 Europe Ischemia Reperfusion Injury Market Size by Type (2016-2027)
7.3 Europe Ischemia Reperfusion Injury Market Size by Application
7.3.1 Europe Ischemia Reperfusion Injury Market Size by Application (2016-2021)
7.3.2 Europe Ischemia Reperfusion Injury Market Size by Application (2022-2027)
7.3.3 Europe Ischemia Reperfusion Injury Market Size by Application (2016-2027)
7.4 Europe Ischemia Reperfusion Injury Market Size by Country
7.4.1 Europe Ischemia Reperfusion Injury Market Size by Country (2016-2021)
7.4.2 Europe Ischemia Reperfusion Injury Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ischemia Reperfusion Injury Market Size (2016-2027)
8.2 Asia-Pacific Ischemia Reperfusion Injury Market Size by Type
8.2.1 Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2016-2027)
8.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Application
8.3.1 Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2016-2027)
8.4 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region
8.4.1 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ischemia Reperfusion Injury Market Size (2016-2027)
9.2 Latin America Ischemia Reperfusion Injury Market Size by Type
9.2.1 Latin America Ischemia Reperfusion Injury Market Size by Type (2016-2021)
9.2.2 Latin America Ischemia Reperfusion Injury Market Size by Type (2022-2027)
9.2.3 Latin America Ischemia Reperfusion Injury Market Size by Type (2016-2027)
9.3 Latin America Ischemia Reperfusion Injury Market Size by Application
9.3.1 Latin America Ischemia Reperfusion Injury Market Size by Application (2016-2021)
9.3.2 Latin America Ischemia Reperfusion Injury Market Size by Application (2022-2027)
9.3.3 Latin America Ischemia Reperfusion Injury Market Size by Application (2016-2027)
9.4 Latin America Ischemia Reperfusion Injury Market Size by Country
9.4.1 Latin America Ischemia Reperfusion Injury Market Size by Country (2016-2021)
9.4.2 Latin America Ischemia Reperfusion Injury Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ischemia Reperfusion Injury Market Size (2016-2027)
10.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Type
10.2.1 Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2016-2027)
10.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Application
10.3.1 Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2016-2027)
10.4 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country
10.4.1 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Angion Biomedica
11.1.1 Angion Biomedica Company Details
11.1.2 Angion Biomedica Business Overview
11.1.3 Angion Biomedica Ischemia Reperfusion Injury Introduction
11.1.4 Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.1.5 Angion Biomedica Recent Development
11.2 Catalyst Biosciences
11.2.1 Catalyst Biosciences Company Details
11.2.2 Catalyst Biosciences Business Overview
11.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Introduction
11.2.4 Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.2.5 Catalyst Biosciences Recent Development
11.3 Ischemix Inc
11.3.1 Ischemix Inc Company Details
11.3.2 Ischemix Inc Business Overview
11.3.3 Ischemix Inc Ischemia Reperfusion Injury Introduction
11.3.4 Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.3.5 Ischemix Inc Recent Development
11.4 Opsona Therapeutics
11.4.1 Opsona Therapeutics Company Details
11.4.2 Opsona Therapeutics Business Overview
11.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Introduction
11.4.4 Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.4.5 Opsona Therapeutics Recent Development
11.5 Pharming
11.5.1 Pharming Company Details
11.5.2 Pharming Business Overview
11.5.3 Pharming Ischemia Reperfusion Injury Introduction
11.5.4 Pharming Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.5.5 Pharming Recent Development
11.6 TheraSource
11.6.1 TheraSource Company Details
11.6.2 TheraSource Business Overview
11.6.3 TheraSource Ischemia Reperfusion Injury Introduction
11.6.4 TheraSource Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.6.5 TheraSource Recent Development
11.7 Bolder Biotechnology
11.7.1 Bolder Biotechnology Company Details
11.7.2 Bolder Biotechnology Business Overview
11.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Introduction
11.7.4 Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.7.5 Bolder Biotechnology Recent Development
11.8 Corline Biomedical
11.8.1 Corline Biomedical Company Details
11.8.2 Corline Biomedical Business Overview
11.8.3 Corline Biomedical Ischemia Reperfusion Injury Introduction
11.8.4 Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.8.5 Corline Biomedical Recent Development
11.9 Mifcortx
11.9.1 Mifcortx Company Details
11.9.2 Mifcortx Business Overview
11.9.3 Mifcortx Ischemia Reperfusion Injury Introduction
11.9.4 Mifcortx Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.9.5 Mifcortx Recent Development
11.10 Balmes Transplantation
11.10.1 Balmes Transplantation Company Details
11.10.2 Balmes Transplantation Business Overview
11.10.3 Balmes Transplantation Ischemia Reperfusion Injury Introduction
11.10.4 Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.10.5 Balmes Transplantation Recent Development
11.11 NovelMed Therapeutics
11.11.1 NovelMed Therapeutics Company Details
11.11.2 NovelMed Therapeutics Business Overview
11.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Introduction
11.11.4 NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.11.5 NovelMed Therapeutics Recent Development
11.12 Hope Pharmaceuticals
11.12.1 Hope Pharmaceuticals Company Details
11.12.2 Hope Pharmaceuticals Business Overview
11.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Introduction
11.12.4 Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.12.5 Hope Pharmaceuticals Recent Development
11.13 Omeros Corp
11.13.1 Omeros Corp Company Details
11.13.2 Omeros Corp Business Overview
11.13.3 Omeros Corp Ischemia Reperfusion Injury Introduction
11.13.4 Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.13.5 Omeros Corp Recent Development
11.14 Prothix
11.14.1 Prothix Company Details
11.14.2 Prothix Business Overview
11.14.3 Prothix Ischemia Reperfusion Injury Introduction
11.14.4 Prothix Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.14.5 Prothix Recent Development
11.15 SBI Pharmaceuticals
11.15.1 SBI Pharmaceuticals Company Details
11.15.2 SBI Pharmaceuticals Business Overview
11.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Introduction
11.15.4 SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2016-2021)
11.15.5 SBI Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ischemia Reperfusion Injury Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Phase 1
Table 3. Key Players of Phase 2
Table 4. Key Players of Preclinical
Table 5. Global Ischemia Reperfusion Injury Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ischemia Reperfusion Injury Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ischemia Reperfusion Injury Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Ischemia Reperfusion Injury Market Share by Regions (2016-2021)
Table 9. Global Ischemia Reperfusion Injury Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Ischemia Reperfusion Injury Market Share by Regions (2022-2027)
Table 11. Ischemia Reperfusion Injury Market Trends
Table 12. Ischemia Reperfusion Injury Market Drivers
Table 13. Ischemia Reperfusion Injury Market Challenges
Table 14. Ischemia Reperfusion Injury Market Restraints
Table 15. Global Ischemia Reperfusion Injury Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Ischemia Reperfusion Injury Market Share by Players (2016-2021)
Table 17. Global Top Ischemia Reperfusion Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemia Reperfusion Injury as of 2020)
Table 18. Ranking of Global Top Ischemia Reperfusion Injury Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Ischemia Reperfusion Injury Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ischemia Reperfusion Injury Product Solution and Service
Table 22. Date of Enter into Ischemia Reperfusion Injury Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2016-2021)
Table 26. Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Ischemia Reperfusion Injury Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2016-2021)
Table 30. Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Ischemia Reperfusion Injury Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Ischemia Reperfusion Injury Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Ischemia Reperfusion Injury Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Ischemia Reperfusion Injury Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Ischemia Reperfusion Injury Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Ischemia Reperfusion Injury Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Ischemia Reperfusion Injury Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2022-2027) & (US$ Million)
Table 62. Angion Biomedica Company Details
Table 63. Angion Biomedica Business Overview
Table 64. Angion Biomedica Ischemia Reperfusion Injury Product
Table 65. Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 66. Angion Biomedica Recent Development
Table 67. Catalyst Biosciences Company Details
Table 68. Catalyst Biosciences Business Overview
Table 69. Catalyst Biosciences Ischemia Reperfusion Injury Product
Table 70. Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 71. Catalyst Biosciences Recent Development
Table 72. Ischemix Inc Company Details
Table 73. Ischemix Inc Business Overview
Table 74. Ischemix Inc Ischemia Reperfusion Injury Product
Table 75. Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 76. Ischemix Inc Recent Development
Table 77. Opsona Therapeutics Company Details
Table 78. Opsona Therapeutics Business Overview
Table 79. Opsona Therapeutics Ischemia Reperfusion Injury Product
Table 80. Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 81. Opsona Therapeutics Recent Development
Table 82. Pharming Company Details
Table 83. Pharming Business Overview
Table 84. Pharming Ischemia Reperfusion Injury Product
Table 85. Pharming Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 86. Pharming Recent Development
Table 87. TheraSource Company Details
Table 88. TheraSource Business Overview
Table 89. TheraSource Ischemia Reperfusion Injury Product
Table 90. TheraSource Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 91. TheraSource Recent Development
Table 92. Bolder Biotechnology Company Details
Table 93. Bolder Biotechnology Business Overview
Table 94. Bolder Biotechnology Ischemia Reperfusion Injury Product
Table 95. Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 96. Bolder Biotechnology Recent Development
Table 97. Corline Biomedical Company Details
Table 98. Corline Biomedical Business Overview
Table 99. Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 100. Corline Biomedical Recent Development
Table 101. Mifcortx Company Details
Table 102. Mifcortx Business Overview
Table 103. Mifcortx Ischemia Reperfusion Injury Product
Table 104. Mifcortx Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 105. Mifcortx Recent Development
Table 106. Balmes Transplantation Company Details
Table 107. Balmes Transplantation Business Overview
Table 108. Balmes Transplantation Ischemia Reperfusion Injury Product
Table 109. Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 110. Balmes Transplantation Recent Development
Table 111. NovelMed Therapeutics Company Details
Table 112. NovelMed Therapeutics Business Overview
Table 113. NovelMed Therapeutics Ischemia Reperfusion Injury Product
Table 114. NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 115. NovelMed Therapeutics Recent Development
Table 116. Hope Pharmaceuticals Company Details
Table 117. Hope Pharmaceuticals Business Overview
Table 118. Hope Pharmaceuticals Ischemia Reperfusion Injury Product
Table 119. Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 120. Hope Pharmaceuticals Recent Development
Table 121. Omeros Corp Company Details
Table 122. Omeros Corp Business Overview
Table 123. Omeros Corp Ischemia Reperfusion Injury Product
Table 124. Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 125. Omeros Corp Recent Development
Table 126. Prothix Company Details
Table 127. Prothix Business Overview
Table 128. Prothix Ischemia Reperfusion Injury Product
Table 129. Prothix Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 130. Prothix Recent Development
Table 131. SBI Pharmaceuticals Company Details
Table 132. SBI Pharmaceuticals Business Overview
Table 133. SBI Pharmaceuticals Ischemia Reperfusion Injury Product
Table 134. SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2016-2021) & (US$ Million)
Table 135. SBI Pharmaceuticals Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ischemia Reperfusion Injury Market Share by Type: 2020 VS 2027
Figure 2. Phase 1 Features
Figure 3. Phase 2 Features
Figure 4. Preclinical Features
Figure 5. Global Ischemia Reperfusion Injury Market Share by Application: 2020 VS 2027
Figure 6. Heart Injury Case Studies
Figure 7. Kidney Injury Case Studies
Figure 8. Intestine Injury Case Studies
Figure 9. Other Injury Case Studies
Figure 10. Ischemia Reperfusion Injury Report Years Considered
Figure 11. Global Ischemia Reperfusion Injury Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Ischemia Reperfusion Injury Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Ischemia Reperfusion Injury Market Share by Regions: 2020 VS 2027
Figure 14. Global Ischemia Reperfusion Injury Market Share by Regions (2022-2027)
Figure 15. Global Ischemia Reperfusion Injury Market Share by Players in 2020
Figure 16. Global Top Ischemia Reperfusion Injury Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ischemia Reperfusion Injury as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Ischemia Reperfusion Injury Revenue in 2020
Figure 18. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2016-2021)
Figure 19. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2022-2027)
Figure 20. North America Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Ischemia Reperfusion Injury Market Share by Type (2016-2027)
Figure 22. North America Ischemia Reperfusion Injury Market Share by Application (2016-2027)
Figure 23. North America Ischemia Reperfusion Injury Market Share by Country (2016-2027)
Figure 24. United States Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ischemia Reperfusion Injury Market Share by Type (2016-2027)
Figure 28. Europe Ischemia Reperfusion Injury Market Share by Application (2016-2027)
Figure 29. Europe Ischemia Reperfusion Injury Market Share by Country (2016-2027)
Figure 30. Germany Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ischemia Reperfusion Injury Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Ischemia Reperfusion Injury Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Ischemia Reperfusion Injury Market Share by Region (2016-2027)
Figure 40. China Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ischemia Reperfusion Injury Market Share by Type (2016-2027)
Figure 48. Latin America Ischemia Reperfusion Injury Market Share by Application (2016-2027)
Figure 49. Latin America Ischemia Reperfusion Injury Market Share by Country (2016-2027)
Figure 50. Mexico Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ischemia Reperfusion Injury Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Ischemia Reperfusion Injury Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Ischemia Reperfusion Injury Market Share by Country (2016-2027)
Figure 56. Turkey Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Ischemia Reperfusion Injury Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Angion Biomedica Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 60. Catalyst Biosciences Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 61. Ischemix Inc Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 62. Opsona Therapeutics Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 63. Pharming Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 64. TheraSource Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 65. Bolder Biotechnology Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 66. Corline Biomedical Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 67. Mifcortx Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 68. Balmes Transplantation Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 69. NovelMed Therapeutics Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 70. Hope Pharmaceuticals Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 71. Omeros Corp Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 72. Prothix Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 73. SBI Pharmaceuticals Revenue Growth Rate in Ischemia Reperfusion Injury Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の虚血再灌流傷害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ischemia Reperfusion Injury Therapeutics Market The global Ischemia Reperfusion Injury Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…- 世界の急性期脊髄損傷市場規模・現状・予測（2021年-2027年） Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children. The treatment of acute spinal cord injury is dependent on few f…
- 世界の外傷性脳損傷診断装置市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Traumatic Brain Injury Diagnostic Equipment Market The global Traumatic Brain Injury Diagnostic Equipment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の外傷性脳損傷診断装置市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Traumatic Brain Injury Diagnostic Equipment Market The global Traumatic Brain Injury Diagnostic Equipment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の急性肺損傷（ALI）市場規模・現状・予測（2021年-2027年） Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Market Analysis and Insights: Global Acute Lung Injury Market The glob…